A therapeutic vulnerability linking MNK1/2 inhibition and G1/S cyclin-dependent kinase blockade in triple-negative breast cancer
Qiyun Deng, Mehdi Amiri, Andia Moshari, Binadi Diddeniya, Parastoo Akbarnia, Anastasija Ana Piric, Érika Prando Munhoz, Yasaman Bagherian, Zilan Li, Michael A. Bellucci, Niaz Mahmood, Michaël Pollak, Sidong Huang, Nahum Sonenberg
This study identifies a synergistic therapeutic effect of combining MNK1/2 inhibition with G1/S CDK blockade in triple-negative breast cancer.
bioRxiv · Sep 16, 2026 · PreprintCancer Biology